Clinical trial
Disturbed Sleep Model Study.
NCT00440323 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00440323 |
|---|---|
| Title | Disturbed Sleep Model Study. |
| Official title | A Double-blind, Double-dummy, Randomised, Placebo-controlled,Four-way Crossover Study to Investigate the Effect of Single Oral Doses of SB-649868 and of Zolpidem in a Model of Noise Induced Situational Insomnia in Healthy Male Volunteers. |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Sleep Initiation and Maintenance Disorders |
| Intervention type | Drug |
| Interventions | SB-649868, Zolpidem, Placebo |
| Enrollment | 52 |
| Start date | Jan 5, 2007 |
| Primary completion | Jul 3, 2007 |
| Completion | Jul 3, 2007 |
| First posted | Feb 27, 2007 |
| Last update posted | Aug 17, 2017 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: